Evidence map›Paper›PMID 32149013›Full record

ReviewKidney international supplements2020

Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world.

Barnaby Hole, Brenda Hemmelgarn, Edwina Brown, Mark Brown, Mignon I McCulloch, Carlos Zuniga, Sharon P Andreoli, Peter G Blake, Cécile Couchoud, Alfonso M Cueto-Manzano and 18 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Kidney international supplements, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Association between serum βBMC nephrology · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 13 countries.

Barnaby HoleUK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK.
Brenda HemmelgarnDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Edwina BrownImperial College Healthcare National Health Service Trust, London, UK.
Mark BrownDepartment of Renal Medicine, St. George Hospital, Sydney, New South Wales, Australia.
Mignon I McCullochPaediatric Intensive and Critical Unit, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
Carlos ZunigaSchool of Medicine, Catholic University of Santisima Concepción, Advanced Renal Care Unit - Las Higueras Hospital, Talcahuano, Chile.
Sharon P AndreoliDepartment of Pediatrics, Pediatric Nephrology, Indiana University Medical Center, Indianapolis, Indiana, USA.
Peter G BlakeOntario Renal Network, Toronto, Ontario, Canada.
Cécile CouchoudFrench Renal Epidemiology and Information Network (REIN) Registry, Biomedicine Agency, Paris, France.
Alfonso M Cueto-ManzanoUnidad de Investigación Médica en Enfermedades Renales, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.
Gavin DreyerDepartment of Nephrology, Barts Health National Health Service Trust, London, UK.
Guillermo Garcia GarciaServicio de Nefrologia, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Hospital 278, Guadalajara, Jalisco, Mexico.
Kitty J JagerThe European Renal Association - European Dialysis and Transplant Association Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.
Marla McKnightRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Rachael L MortonNational Health and Medical Research Council Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
Fliss E M MurtaghWolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.
Saraladevi NaickerSchool of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Gregorio T ObradorUniversidad Panamericana Faculty of Health Sciences and School of Medicine, Mexico City, Mexico.
Jeffrey PerlDivision of Nephrology, St. Michael's Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Muhibur RahmanDepartment of Nephrology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh.
Kamal D ShahNephroPlus Dialysis Centres, Hyderabad, India.
Wim Van BiesenNephrology Department, Ghent University Hospital, Ghent, Belgium.
Rachael C WalkerSchool of Nursing, Eastern Institute of Technology, Napier, New Zealand.
Karen YeatesDivision of Nephrology, Queen's University, Kingston, Ontario, Canada.
Alexander ZemchenkovDepartment of Internal Disease and Nephrology, North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia.
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Simon J DaviesFaculty of Medicine and Health Sciences, Keele University, Keele, UK.
Fergus J CaskeyUK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK.
National Health Service · GBAgence de la Biomédecine · FRBrigham and Women's Hospital · USEastern Institute of Technology · NZFirst Pavlov State Medical University of St. Petersburg · RUGhent University Hospital · BEKeele University · GBMexican Social Security Institute · MXMinistry of Education of the People's Republic of China · CNMitford Hospital, DhakaQueen's University · CARenal Association · GBSouthmead Hospital · GBSt George Hospital · AUSt. Michael's Hospital · CAThe University of Sydney · AUUniversidad de Guadalajara · MXUniversidad Panamericana · MXUniversity Medical Center · USUniversity of Calgary · CA

Funding

Department of Health DRF-2017-10-127
6 · The paper itself

Abstract

A key component of treatment for all people with advanced kidney disease is supportive care, which aims to improve quality of life and can be provided alongside therapies intended to prolong life, such as dialysis. This article addresses the key considerations of supportive care as part of integrated end-stage kidney disease care, with particular attention paid to programs in low- and middle-income countries. Supportive care should be an integrated component of care for patients with advanced chronic kidney disease, patients receiving kidney replacement therapy (KRT), and patients receiving non-KRT conservative care. Five themes are identified: improving information on prognosis and support, developing context-specific evidence, establishing appropriate metrics for monitoring care, clearly communicating the role of supportive care, and integrating supportive care into existing health care infrastructures. This report explores some general aspects of these 5 domains, before exploring their consequences in 4 health care situations/settings: in people approaching end-stage kidney disease in high-income countries and in low- and middle-income countries, and in people discontinuing KRT in high-income countries and in low- and middle-income countries.

Indexed as

conservative careend-stage kidney diseasepalliative caresupportive care

Identifiers

PMID32149013
PMCPMC7031687
OpenAlexW3008979800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.